"You get what you pay for" often applies to expensive stocks with best-in-class business models and execution. While their quality can sometimes justify the premium, they typically experience elevated volatility during market downturns when expectations change.
Separating true intrinsic value from speculation isn’t easy, especially during bull markets. That’s where StockStory comes in - to help you find high-quality companies that will stand the test of time. Keeping that in mind, here is one high-flying stock expanding its competitive advantage and two where the price is not right.
Two High-Flying Stocks to Sell:
SiteOne (SITE)
Forward P/E Ratio: 32.6x
Known for distributing John Deere tractors and LESCO turf care products, SiteOne Landscape Supply (NYSE: SITE) provides landscaping products and services to professionals, including irrigation, lighting, and nursery supplies.
Why Do We Think SITE Will Underperform?
- Absence of organic revenue growth over the past two years suggests it may have to lean into acquisitions to drive its expansion
- Earnings per share fell by 3.9% annually over the last two years while its revenue grew, showing its incremental sales were much less profitable
- Eroding returns on capital suggest its historical profit centers are aging
SiteOne is trading at $142.86 per share, or 32.6x forward P/E. If you’re considering SITE for your portfolio, see our FREE research report to learn more.
Zurn Elkay (ZWS)
Forward P/E Ratio: 30.7x
Claiming to have saved more than 30 billion gallons of water, Zurn Elkay (NYSE: ZWS) provides water management solutions to various industries.
Why Are We Cautious About ZWS?
- Organic revenue growth fell short of our benchmarks over the past two years and implies it may need to improve its products, pricing, or go-to-market strategy
- Performance over the past five years was negatively impacted by new share issuances as its earnings per share fell by 3% annually while its revenue was flat
- Capital intensity has ramped up over the last five years as its free cash flow margin decreased by 3.3 percentage points
Zurn Elkay’s stock price of $50.95 implies a valuation ratio of 30.7x forward P/E. Read our free research report to see why you should think twice about including ZWS in your portfolio.
One High-Flying Stock to Buy:
Alignment Healthcare (ALHC)
Forward P/E Ratio: 46.7x
Founded in 2013 with a mission to transform healthcare for seniors, Alignment Healthcare (NASDAQ: ALHC) provides Medicare Advantage health plans for seniors with features like concierge services, transportation benefits, and technology-driven care coordination.
Why Are We Bullish on ALHC?
- Customer trends over the past two years show it’s maintaining a steady flow of new contracts that can potentially increase in value over time
- Earnings per share grew by 27.7% annually over the last four years, massively outpacing its peers
- Free cash flow flipped to positive over the last five years, showing the company is at an important crossroads
At $19.70 per share, Alignment Healthcare trades at 46.7x forward P/E. Is now the right time to buy? See for yourself in our in-depth research report, it’s free.
Stocks We Like Even More
ALSO WORTH WATCHING: Top 5 Momentum Stocks. The best time to own a great stock is when the market is finally noticing it. These aren't just high-quality businesses. Something is happening with them right now. Elite fundamentals meeting near-term momentum — both boxes checked at the same time.
Find out which stocks our AI platform is flagging this week. See this week's Strong Momentum stocks — FREE. Get Our Strong Momentum Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,754% five-year return). Find your next big winner with StockStory today.
